Explore Decure’s sourcing portfolio across injectables, tablets, capsules, dry syrups, topical formulations and specialized therapeutic ranges, with multiple strengths, compositions and dosage-form options for institutional and commercial requirements.
8+Product Categories
500+Product Variants
MultipleDosage Forms
GMPQuality Sourced
Sterile injectable formulations for institutional and hospital requirements.
Beta-Lactam and Non-Beta-Lactam formulations across therapeutic categories.
Hard-shell capsule formulations in multiple strengths and compositions.
Paediatric and adult oral liquid and dry-syrup formulation options.
Creams, ointments and other topical dosage-form requirements.
Formulations supporting diabetes-management sourcing requirements.
Cardiovascular formulations across common dosage forms and strengths.
Page 3 of 22
Oral Suspension / Dry Syrup
Artemether 20mg + Lumefantine 120mg/5ml Oral Suspension is a oral suspension / dry syrup formulated with Artemether 20mg + Lumefantine 120mg/5ml. The listed active ingredient profile is Artemether; Lumefantine, placing the product in the antimalarial cate
Oral Suspension / Dry Syrup
Artemether 80mg and Lumefantrine 480mg /5ml Oral Suspension is a oral suspension / dry syrup formulated with Artemether 80mg and Lumefantrine 480mg /5ml. The listed active ingredient profile is Artemether and Lumefantrine, placing the product in the antim
Tablet
Atorvastatin 10mg + Fenofibrate 160mg Tab. (Film coated) is a tablet formulated with Atorvastatin 10mg + Fenofibrate 160mg . ( ). The listed active ingredient profile is Atorvastatin; Fenofibrate, placing the product in the lipid-lowering therapy category
Tablet
Atorvastatin 10mg Tab. (Film Coated) is a tablet formulated with Atorvastatin 10mg . ( ). The listed active ingredient profile is Atorvastatin, placing the product in the lipid-lowering therapy category. The formulation contains lipid-lowering medicine(s)
Tablet
Atorvastatin 20mg Tab. (Film) is a tablet formulated with Atorvastatin 20mg . (Film). The listed active ingredient profile is Atorvastatin, placing the product in the lipid-lowering therapy category. The formulation contains lipid-lowering medicine(s) use
Oral Suspension / Dry Syrup
Azithromycin 100mg /5ml Oral Suspension is a oral suspension / dry syrup formulated with Azithromycin 100mg /5ml. The listed active ingredient profile is Azithromycin, placing the product in the antibacterial category. The active ingredient is an antibact
Tablet
Azithromycin 250 mg + Lactic Acid Bacillus 60 MS Tablet is a tablet formulated with Azithromycin 250 mg + Lactic Acid Bacillus 60 MS. The active ingredient profile is Azithromycin; Lactic Acid Bacillus, placing the product in the macrolide antibiotic + pr
Film-Coated Tablet
Azithromycin 250 mg Film-Coated Tablet is a film-coated tablet formulated with 250 mg. The active ingredient profile is Azithromycin, placing the product in the macrolide antibiotic category. Azithromycin is a macrolide antibiotic that suppresses bacteria
Film-Coated Combination Tablet
Azithromycin 500 mg + Ambroxol SR 75 mg Film-Coated Tablet is a film-coated combination tablet formulated with Azithromycin 500 mg + Ambroxol SR 75 mg. The active ingredient profile is Azithromycin; Ambroxol, placing the product in the macrolide antibioti
Topical Formulation
Beclomehasone Dipropionate 0.025%w/w + Salicylic Acid 3%w/w is a topical formulation formulated with Beclomehasone Dipropionate 0.025%w/w + Salicylic Acid 3%w/w. The listed active ingredient profile is Beclomehasone Dipropionate w/w; Salicylic Acid w/w, p
Ointment
Beclomenthasone Dipropionate USP 0.025%w/w + Salicylic Acid IP 37%w/w Ointment is a ointment formulated with Beclomenthasone Dipropionate USP 0.025%w/w + Salicylic Acid IP 37%w/w. The listed active ingredient profile is Beclomenthasone Dipropionate w/w; S
Topical Formulation
Beclomethasone Diprolplonate 0.02%w/w + Clotrimazole l1%w/w is a topical formulation formulated with Beclomethasone Diprolplonate 0.02%w/w + Clotrimazole l1%w/w. The listed active ingredient profile is Beclomethasone Diprolplonate w/w; Clotrimazole l1%w/w
Cream
Beclomethasone Dipropionate IP 0.0257%w/w Cream is a cream formulated with Beclomethasone Dipropionate IP 0.0257%w/w. The listed active ingredient profile is Beclomethasone Dipropionate w/w, placing the product in the topical anti-inflammatory / dermatolo
Topical Formulation
Beclomethasone Diproplonate 0.025%wtw is a topical formulation formulated with Beclomethasone Diproplonate 0.025%wtw. The listed active ingredient profile is Beclomethasone Diproplonate wtw, placing the product in the topical anti-inflammatory / dermatolo
Topical Formulation
Beclomethasone Diproplonate 0.025°/0w/w + Ketoconazole 2% w/w is a topical formulation formulated with Beclomethasone Diproplonate 0.025°/0w/w + Ketoconazole 2% w/w. The listed active ingredient profile is Beclomethasone Diproplonate °; Ketoconazole % w/w
Cream
Beclomethgsone Dipropionate IP 0.025%w/w + Ketoconazole 2%w/w Cream is a cream formulated with Beclomethgsone Dipropionate IP 0.025%w/w + Ketoconazole 2%w/w. The listed active ingredient profile is Beclomethgsone Dipropionate w/w; Ketoconazole w/w, placin
Hard Gelatin Capsule
Benfotiamine 15 mg + Methylcobalamin IP 1500 mcg + Alpha Lipoic Acid USP 100 mg + Chromium Polynicotinate 65 mcg + Folic Acid IP 1.5 mg + Inositol 10 mcg + Vitamin B6 3 mg + Calcium Pantothenate 25 mg Zinc Oxide 22.5 mg + Lutcin 5 mg (Hard Gelatin Cap) is
Uncoated Tablet
Betahistine Hydrochloride 8 mg Uncoated Tablet is a uncoated tablet formulated with 8 mg. The active ingredient profile is Betahistine Hydrochloride, placing the product in the antivertigo agent category. Betahistine is an antivertigo medicine used in sel
Topical Formulation
Betamethasone Dipropionate 0.25 mg + fusidic Acid 20 mg + Chlorocresol 1.2 mg is a topical formulation formulated with Betamethasone Dipropionate 0.25 mg + fusidic Acid 20 mg + Chlorocresol 1.2 mg. The listed active ingredient profile is Betamethasone Dip
Topical Formulation
Betamethasone Dipropionate 0.64 mg + Salicylic Acid 30 mg is a topical formulation formulated with Betamethasone Dipropionate 0.64 mg + Salicylic Acid 30 mg. The listed active ingredient profile is Betamethasone Dipropionate; Salicylic Acid, placing the p
Topical Formulation
Betamethasone Dipropionate IP 0.25 mg + Fusidic Acid IP 20 mg Chlorocresol lp 1.2 mg is a topical formulation formulated with Betamethasone Dipropionate IP 0.25 mg + Fusidic Acid IP 20 mg Chlorocresol lp 1.2 mg. The listed active ingredient profile is Bet
GMP Certified Manufacturers
Wide Product Portfolio
Multiple Dosage Forms
Global Supply Network
Regulatory Documentation
Competitive PricingOur sourcing experts are ready to help with custom requirements, supply availability and regulatory documentation.
